Download PDF
1 / Pages

Other users also viewed these articles

Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
Epidemiology and natural history of chronic Hepatitis B in the Canadian province of Alberta from 2012 to 2021: A population-based study Golasa Samadi Kochaksaraei; Fengjuan Yang; Cynthia H. Seow; Herman W Barkema; Carla S Coffin; Abdel-Aziz Shaheen;
10.1016/j.aohep.2024.101576
cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B Patricia Gita Naully; Marselina Irasonia Tan; Agustiningsih Agustiningsih; Caecilia Sukowati; Ernawati Arifin Giri-Rachman;
10.1016/j.aohep.2024.101533